Viewing Study NCT01115803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-01-12 @ 6:04 PM
Study NCT ID: NCT01115803
Status: TERMINATED
Last Update Posted: 2019-02-05
First Post: 2010-04-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastases, Neoplasm View
None Carcinoma, Non-small Cell Lung View
None Renal Cell Carcinoma View
None Neuroendocrine Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Cancer View
None Metastatic Cancer View
None Non-Small Cell Lung Cancer View
None Renal Cell Carcinoma View
None Neuroendocrine Tumors View